// author archive

Carl-Henrik Brogren

Carl-Henrik Brogren has written 24 posts for ImmunoSigns

Collaboration with MelliTech, Grenoble, France, on the specificity of monoclonal IC2

License & research collaboration with MelliTech, Grenoble, France, concerning the monoclonal autoantibody IC2 and the ZnT8-transporter in pancreatic beta-cells.

Pilot commercial productions of the monoclonal autoantibody IC2

R&D collaboration with The Danish State Serum Institute, Copenhagen, Denmark  concerning pilot production of the beta-cell specific monoclonal autoantibody IC2. The pilot preparation has been tested in Paris and Copenhagen. The unique specificity of IC2 against the plasma membrane of insulin-producing beta-cells was confirmed. Possible outsourcing contract with the biotech company Exbio, Prague, for a […]

Pure Tech Ventures in Boston express interest for innovative new imaging application with IC2

The Boston company, Pure Tech Ventures, express interest for licensing and partnership  for R&D collaboration in the field of medical imaging.

European RTD project planed on pancreatic beta-cell imaging in vitro and in vivo

EU-consortium meet in Copenhagen to discuss multiple application of the monoclonal autoantibody IC2 in noninvasive medical imaging by MRI, SPECT, PET and other innovative new methods.